BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24745683)

  • 1. Neuropsychological features of adult mastocytosis.
    Moura DS; Georgin-Lavialle S; Gaillard R; Hermine O
    Immunol Allergy Clin North Am; 2014 May; 34(2):407-22. PubMed ID: 24745683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting c-kit in the therapy of mast cell disorders: current update.
    El-Agamy DS
    Eur J Pharmacol; 2012 Sep; 690(1-3):1-3. PubMed ID: 22789565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytosis: advances in diagnosis and treatment.
    Hungness SI; Akin C
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):248-54. PubMed ID: 17547845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastocytosis in adulthood and neuropsychiatric disorders.
    Georgin-Lavialle S; Gaillard R; Moura D; Hermine O
    Transl Res; 2016 Aug; 174():77-85.e1. PubMed ID: 27063957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.
    Bibi S; Arock M
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):527-543. PubMed ID: 30007468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mastocytosis.
    George TI; Horny HP
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):1067-83, vii. PubMed ID: 22054735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.
    Moura DS; Sultan S; Georgin-Lavialle S; Barete S; Lortholary O; Gaillard R; Hermine O
    PLoS One; 2012; 7(6):e39468. PubMed ID: 22745762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors.
    Pittoni P; Piconese S; Tripodo C; Colombo MP
    Oncogene; 2011 Feb; 30(7):757-69. PubMed ID: 21057534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategies in mastocytosis.
    Siebenhaar F; Akin C; Bindslev-Jensen C; Maurer M; Broesby-Olsen S
    Immunol Allergy Clin North Am; 2014 May; 34(2):433-47. PubMed ID: 24745685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT and mastocytosis.
    Lim KH; Pardanani A; Tefferi A
    Acta Haematol; 2008; 119(4):194-8. PubMed ID: 18566536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
    Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastocytosis.
    Metcalfe DD
    Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.
    Jensen BM; Akin C; Gilfillan AM
    Br J Pharmacol; 2008 Aug; 154(8):1572-82. PubMed ID: 18500355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thiazole amine class tyrosine kinase inhibitors induce apoptosis in human mast cells expressing D816V KIT mutation.
    Jin Y; Ding K; Wang D; Shen M; Pan J
    Cancer Lett; 2014 Oct; 353(1):115-23. PubMed ID: 25088577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
    Georgin-Lavialle S; Lhermitte L; Suarez F; Yang Y; Letard S; Hanssens K; Feger F; Renand A; Brouze C; Canioni D; Asnafi V; Chandesris MO; Aouba A; Gineste P; Macintyre E; Mansfield CD; Moussy A; Lepelletier Y; Dubreuil P; Hermine O
    Eur J Haematol; 2012 Jul; 89(1):47-52. PubMed ID: 22324351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastocytosis - an update.
    Amon U; Hartmann K; Horny HP; Nowak A
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast Cells, Mastocytosis, and Related Disorders.
    Theoharides TC; Valent P; Akin C
    N Engl J Med; 2015 Jul; 373(2):163-72. PubMed ID: 26154789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.